Amdocs DOX Drops Sharply on Miss and weak FY27 guidance
Nov 4, 2026, 8:32 AM EST1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
The stock tumbled 39.1% premarket on a below-consensus FY27 outlook, signaling significant near-term downside risk and potential multiple re-rating if guidance persists. Historically, such guidance disappointments in software/services can lead to sustained selling until the company demonstrates a clear path to growth and margin recovery.
AI summary
What happened, with direct paths to the underlying reporting
Amdocs (DOX) reported a Q4 miss with EPS of $1.98 (vs $1.99 expected) and revenue of $1.194 billion, guiding FY27 below consensus. The stock fell about 39% premarket to $38, signaling outsized negative sentiment and potential further downside as investors reassess growth and margins. The negative read may put near-term pressure on multiple-iteration software/IT services names until clearer visibility emerges.
Amdocs DOX Q4 EPS $1.98 vs $1.99 est; revenue $1.194B vs est.
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
Amdocs' Q4 earnings report set for Nov. 11, predicting $1.82 per share. Quarterly revenue expected at $1.15 billion, down from $1.26 billion last year. Signed multi-year agreement…